Headache Cooperative of New England 32nd Annual Stowe Headache Conference (Hybrid) - April 1 - 2, 2022
Thank you for participating in this program. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to complete the evaluation and claim your credit on the following page.
This program is a comprehensive overview of the current state of Headache Medicine. This program focuses on an in-depth consideration of specific headache and facial pain topics, with a focus on the most common primary and secondary headache disorders. It is designed to provide more clinically useful detail than a typical continuing medical education program in which a single lecture on headache would be included among lectures on other topics. The course is designed to enable attendees to enhance their clinical and research skills by gaining knowledge in the latest concepts concerning diagnosis, treatment, and mechanisms of the primary and secondary headache disorders.
This program is designed to educate practitioners who have an interest in the diagnosis and management of headache disorders. These include neurologists, primary care providers, dentists, psychologists, nurse practitioners, physician assistants, physical therapists, and other health care providers with an interest in Headache Medicine.
At the conclusion of this activity, the participants will be able to:
- Describe the classification, diagnosis, and treatment alternatives for the common primary headache disorders.
- Conceptualize prodrome, aura and postdrome phases in migraine.
- Recognize "dangerous" secondary headaches
- Plan appropriate acute/abortive, preventive, and rescue treatment of migraine and the trigeminal autonomic cephalalgias (TACS).
- Explain the rationale for the use of monoclonal antibodies in migraine prevention and compare the various CGRP inhibiting mAbs.
- Describe the role of gepants and ditans in the acute and preventive treatment of migraine.
- Differentiate the various neuromodulation approaches in the primary headache disorders.
- Examine the disparities in headache care in the United States.
- Describe the functional and structural brain changes in migraine.
- Discuss the role of the hypothalamus in migraine pathophysiology
- Explain the circadian timing system in relation to cluster headache as well as other head pain states.
- Discuss the role of fear avoidance in migraine and plan effective behavioral interventions.
- Plan interventions for refractory chronic migraine
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and the Headache Cooperative of New England (HCNE).
Boston University School of Medicine designates this live activity for a maximum of 15.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This educational activity has been provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine and jointly-provided by Headache Cooperative of New England.
Contact Hours: 11 of which 3 are pharmacology credit worthy.
- 15.75 AMA PRA Category 1 Credit™Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this Enduring activity for a maximum of 15.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 15.75 ANCCBoston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
- 15.75 Participation
This activity is supported by an educational grant from AbbVie.
This activity is supported by educational funding provided by Amgen
This activity is supported by an educational grant from Lilly.